Osaic Holdings’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$173K	Sell	56,326 -60,640	-52%	-$234K	﹤0.01%	4260
2025 Q4	$478K	Sell	116,966 -136,578	-54%	-$676K	﹤0.01%	3377
2025 Q3	$1.19M	Buy	253,544 +4,947	+2%	+$26K	﹤0.01%	2637
2025 Q2	$1.26M	Sell	248,597 -14,111	-5%	-$69.3K	﹤0.01%	2316
2025 Q1	$1.39M	Buy	262,708 +20,518	+8%	+$150K	﹤0.01%	1954
2024 Q4	$1.64M	Sell	242,190 -39,277	-14%	-$264K	﹤0.01%	1816
2024 Q3	$1.85M	Buy	281,467 +61,519	+28%	+$441K	﹤0.01%	1750
2024 Q2	$1.65M	Buy	219,948 +122,416	+126%	+$1.07M	﹤0.01%	1772
2024 Q1	$972K	Buy	97,532 +37,426	+62%	+$417K	﹤0.01%	2352
2023 Q4	$593K	Buy	60,106 +53,014	+748%	+$378K	﹤0.01%	3011
2023 Q3	$54.2K	Buy	7,092 +3,889	+121%	+$38.8K	﹤0.01%	4948
2023 Q2	$23.9K	Buy	3,203 +129	+4%	+$903	﹤0.01%	5448
2023 Q1	$20.5K	Sell	3,074 -910	-23%	-$7.22K	﹤0.01%	5559
2022 Q4	$30K	Buy	3,984 +599	+18%	+$5.87K	﹤0.01%	5293
2022 Q3	$36K	Buy	3,385 +645	+24%	+$6.53K	﹤0.01%	5155
2022 Q2	$22K	Sell	2,740 -1,068	-28%	-$7.15K	﹤0.01%	5554
2022 Q1	$27K	Buy	3,808 +633	+20%	+$6.73K	﹤0.01%	5497
2021 Q4	$54K	Buy	3,175 +780	+33%	+$14.7K	﹤0.01%	5089
2021 Q3	$54K	Buy	2,395 +505	+27%	+$14.3K	﹤0.01%	5045
2021 Q2	$69K	Buy	+1,890	New	+$55.9K	﹤0.01%	4798